SURF1 Antikörper (N-Term)
Kurzübersicht für SURF1 Antikörper (N-Term) (ABIN926757)
Target
Alle SURF1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- SURF1 antibody was raised in rabbit using the N terminal of SURF1 as the immunogen
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator.
-
Kommentare
-
SURF1 Blocking Peptide, (ABIN938801), is also available for use as a blocking control in assays to test for specificity of this SURF1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- SURF1 (Surfeit 1 (SURF1))
-
Andere Bezeichnung
- SURF1
-
Hintergrund
- This gene encodes a protein localized to the inner mitochondrial membrane and thought to be involved in the biogenesis of the cytochrome c oxidase complex. The protein is a member of the SURF1 family, which includes the related yeast protein SHY1 and rickettsial protein RP733. The gene is located in the surfeit gene cluster, a group of very tightly linked genes that do not share sequence similarity, where it shares a bidirectional promoter with SURF2 on the opposite strand. Defects in this gene are a cause of Leigh syndrome, a severe neurological disorder that is commonly associated with systemic cytochrome c oxidase deficiency. Synonyms: Polyclonal SURF1 antibody, Anti-SURF1 antibody, surfeit 1 antibody.
-
Pathways
- Proton Transport, Ribonucleoside Biosynthetic Process
Target
-